OTCMKTS:PLLWF Polarean Imaging - PLLWF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. $0.25 0.00 (0.00%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.25▼$0.2550-Day Range$0.25▼$0.6552-Week Range$0.25▼$0.82VolumeN/AAverage Volume8,636 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Polarean Imaging (OTCMKTS:PLLWF) StockPolarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.Read More Receive PLLWF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address PLLWF Stock News HeadlinesMarch 13, 2023 | proactiveinvestors.comPolarean calls temporary halt to AIM trading in the wake of SVB collapseFebruary 2, 2023 | proactiveinvestors.comPolarean Imaging hails as a 'major milestone' FDA designation for XENOVIEWMarch 26, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. February 2, 2023 | proactiveinvestors.comPolarean Imaging hails as a 'major milestone' FDA designation for XENOVIEWFebruary 2, 2023 | proactiveinvestors.comPolarean Imaging hails FDA designation for XENOVIEW as a 'major milestone'February 2, 2023 | proactiveinvestors.comPolarean Imaging hails FDA designation for XENOVIEW as a 'major milestone'February 1, 2023 | marketwatch.comPolarean Imaging Shares Rise After FDA Grant on XenoviewDecember 28, 2022 | marketwatch.comPolarean Imaging's Xenoview Gets US FDA ApprovalMarch 26, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. September 30, 2022 | proactiveinvestors.comPolarean Imaging updates on FDA reviewSeptember 23, 2022 | lse.co.ukPolarean Imaging shares dive on FDA additional information requestSeptember 22, 2022 | marketwatch.comPolarean Imaging Shares Fall on FDA's Concerns Over Gas Blend DrugAugust 26, 2022 | proactiveinvestors.comPolarean Imaging appoints Dr Marcella Ruddy as non-executive directorAugust 26, 2022 | proactiveinvestors.comPolarean Imaging PLC appoints Dr Marcella Ruddy as non-executive directorAugust 22, 2022 | finance.yahoo.comPolarean Imaging plc (PLLWF)July 8, 2022 | proactiveinvestors.comPolarean Imaging completes system installation at Cincinnati Children's Hospital Medical CenterMay 20, 2022 | finance.yahoo.comPolarean Imaging (LON:POLX) shareholders have earned a 51% CAGR over the last three yearsMay 18, 2022 | proactiveinvestors.comPolarean Imaging continues preparations for launch pending FDA approvalMay 11, 2022 | proactiveinvestors.comPolarean and Oxford University to collaborate on long Covid studyApril 25, 2022 | proactiveinvestors.comPolarean Imaging secures new system orderMarch 31, 2022 | morningstar.comPolarean Imaging Shares Jump on New FDA SubmissionDecember 31, 2021 | finance.yahoo.comWhat You Need To Know About Polarean Imaging plc's (LON:POLX) Investor CompositionNovember 15, 2021 | finance.yahoo.comMultiple insiders bought Polarean Imaging plc (LON:POLX) stock earlier this year, a positive sign for shareholdersOctober 11, 2021 | marketwatch.comPolarean Imaging Shares Rise on Polarizer System Installation in CanadaOctober 8, 2021 | proactiveinvestors.comPolarean Imaging receives Complete Response Letter from US Food and Drug AdministrationSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PLLWF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PLLWF CUSIPN/A CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Kenneth Paul West (Age 65)Chairman Comp: $38.25kMr. Clairis Richard Hullihen (Age 69)CEO & Director Comp: $348.52kDr. Bastiaan Driehuys Ph.D. (Age 53)Founder, CTO & Director Comp: $43.25kMr. Charles Fremont Osborne Jr. (Age 56)CFO & Director Comp: $315.42kMr. Neil Wadehra (Age 42)VP of Operations Mr. Alex Dusek (Age 55)Chief Commercial Officer Mr. Stephen AustinCompany Sec.More ExecutivesKey CompetitorsBICO Group AB (publ)OTCMKTS:CLLKFCochlearOTCMKTS:CHEOYCochlearOTCMKTS:CHEOFEL.En.OTC:ELEAFElectromedical TechnologiesOTCMKTS:EMEDView All Competitors PLLWF Stock - Frequently Asked Questions How have PLLWF shares performed in 2023? Polarean Imaging's stock was trading at $0.75 at the beginning of 2023. Since then, PLLWF shares have decreased by 66.7% and is now trading at $0.25. View the best growth stocks for 2023 here. What is Polarean Imaging's stock symbol? Polarean Imaging trades on the OTCMKTS under the ticker symbol "PLLWF." How do I buy shares of Polarean Imaging? Shares of PLLWF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Polarean Imaging's stock price today? One share of PLLWF stock can currently be purchased for approximately $0.25. How can I contact Polarean Imaging? Polarean Imaging's mailing address is 27-28 Eastcastle Street, London, Greater London. The official website for the company is www.polarean.com. The company can be reached via phone at 919 206 7900. This page (OTCMKTS:PLLWF) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.